Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study

被引：17
作者：
Wang, Guochang [1 ]
Li, Linlin [1 ]
Wang, Jiarou [1 ]
Zang, Jie [2 ]
Chen, Jingci [3 ]
Xiao, Yu [3 ]
Fan, Xinrong [4 ]
Zhu, Lin [5 ]
Kung, Hank F. F. [6 ]
Zhu, Zhaohui [1 ]
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Nucl Med,State Key Lab Complex Severe & Rare, Beijing 100730, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Nucl Med, Fujian Prov Key Lab Precis Med Canc, Fuzhou 350005, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Pathol, Beijing 100730, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Urol, Beijing 100730, Peoples R China
[5] Beijing Normal Univ, Coll Chem, Key Lab Radiopharmaceut, Minist Educ, Beijing 100875, Peoples R China
[6] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / 05期
基金：
中国国家自然科学基金; 北京市自然科学基金;
关键词：
2-[F-18]FDG; Clear cell renal cell carcinoma; PET; CT; Ga-68]Ga-P16-093; MEMBRANE ANTIGEN-EXPRESSION; PSMA EXPRESSION; CANCER; BIODISTRIBUTION; TOMOGRAPHY; DOSIMETRY; LESIONS; LIGAND; CT;
D O I：
10.1007/s00259-022-06101-3
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Purpose:This pilot study was prospectively designed to evaluate and compare the diagnostic value of PET/CT using a PSMA-specific tracer [Ga-68]Ga-P16-093 and a glucose metabolism probe 2-[F-18]FDG in clear cell renal cell carcinoma (ccRCC) patients. Methods:Forty-two pathologically confirmed ccRCC patients were included. Within 1 week, each patient underwent [Ga-68]Ga-P16-093 and 2-[F-18]FDG PET/CT. In addition to visual analysis of tumor number, the standardized uptake value (SUV) was measured for semiquantitative comparison and correlation analysis. Results:For primary ccRCC patients, [Ga-68]Ga-P16-093 PET/CT demonstrated a significantly higher detection rate (19/22 vs. 13/22, P = 0.031) and higher tumor uptake (15.7 +/- 9.0 vs. 5.1 +/- 3.4, P < 0.001) than 2-[F-18]FDG PET/CT. In addition, the SUVmax of the primary tumor on [Ga-68]Ga-P16-093 and 2-[F-18]FDG PET/CT was significantly correlated with pT stage (for [Ga-68]Ga-P16-093, r = 0.550, P = 0.008; for 2-[F-18]FDG, r = 0.514, P = 0.014) and WHO/ISUP grade (for [Ga-68]Ga-P16-093, r = 0.566, P = 0.006; for 2-[F-18]FDG, r = 0.492, P = 0.020), respectively. For metastatic ccRCC patients, [Ga-68]Ga-P16-093 PET/CT also demonstrated a better detection rate (21/22 vs. 14/22, P = 0.008) and higher tumor uptake (11.0 +/- 6.4 vs. 4.4 +/- 2.7, P < 0.001) than 2-[F-18]FDG PET/CT. The SUVmax on [Ga-68]Ga-P16-093 PET/CT had a significant association with PSMA expression in primary ccRCC (r = 0.776, P < 0.001) and metastatic ccRCC (r = 0.626, P = 0.029). Conclusions:[Ga-68]Ga-P16-093 PET/CT demonstrates significantly better tumor detectability than 2-[F-18]FDG PET/CT for ccRCC patients.
引用
收藏
页码：1499 / 1509
页数：11
相关论文
共 38 条
[1]   The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions [J].
Afshar-Oromieh, Ali ;
Hetzheim, Henrik ;
Kratochwil, Clemens ;
Benesova, Martina ;
Eder, Matthias ;
Neels, Oliver C. ;
Eisenhut, Michael ;
Kuebler, Wolfgang ;
Holland-Letz, Tim ;
Giesel, Frederik L. ;
Mier, Walter ;
Kopka, Klaus ;
Haberkorn, Uwe .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (11) :1697-1705
[2]   Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases:: a comparison with CT [J].
Aide, N ;
Cappele, O ;
Bottet, P ;
Bensadoun, H ;
Regeasse, A ;
Comoz, F ;
Sobrio, F ;
Bouvard, G ;
Agostini, D .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) :1236-1245
[3]   Expression of prostate-specific membrane antigen in renal cortical tumors [J].
Al-Ahmadie, Hikmat A. ;
Olgac, Semra ;
Gregor, Polly D. ;
Tickoo, Satish K. ;
Fine, Samson W. ;
Kondagunta, G. Varuni ;
Scher, Howard I. ;
Morris, Michael J. ;
Russo, Paul ;
Motzer, Robert J. ;
Reuter, Victor E. .
MODERN PATHOLOGY, 2008, 21 (06) :727-732
[4]   68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership [J].
Carlucci, Giuseppe ;
Ippisch, Robin ;
Slavik, Roger ;
Mishoe, Ashley ;
Blecha, Joseph ;
Zhu, Shaojun .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) :149-155
[5]  
Chang SS, 1999, CANCER RES, V59, P3192
[6]   68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [J].
Cytawa, Wojciech ;
Seitz, Anna Katharina ;
Kircher, Stefan ;
Fukushima, Kazuhito ;
Tran-Gia, Johannes ;
Schirbel, Andreas ;
Bandurski, Tomasz ;
Lass, Piotr ;
Krebs, Markus ;
Polom, Wojciech ;
Matuszewski, Marcin ;
Wester, Hans-Juergen ;
Buck, Andreas K. ;
Kuebler, Hubert ;
Lapa, Constantin .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) :168-177
[7]   Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies [J].
Doot, Robert K. ;
Young, Anthony J. ;
Daube-Witherspoon, Margaret E. ;
Alexoff, David ;
Labban, Kyle J. ;
Lee, Hwan ;
Wu, Zehui ;
Zha, Zhihao ;
Choi, Seok R. ;
Ploessl, Karl H. ;
Schubert, Erin K. ;
Lee, Hsiaoju ;
Zhu, Lin ;
Reddin, Janet S. ;
Karp, Joel S. ;
Kung, Hank ;
Pryma, Daniel A. .
NUCLEAR MEDICINE AND BIOLOGY, 2020, 86-87 :1-8
[8]  
Erdi YE, 2004, J NUCL MED, V45, P1287
[9]   Comprehensive evaluation of68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma [J].
Gao, Jie ;
Xu, Qinfeng ;
Fu, Yao ;
He, Kuiqiang ;
Zhang, Chengwei ;
Zhang, Qing ;
Shi, Jiong ;
Zhao, Xiaozhi ;
Wang, Feng ;
Guo, Hongqian .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) :561-569
[10]   Dynamic 68Ga-PSMA-11 PET/CT for the Primary Evaluation of Localized Renal Mass: A Prospective Study [J].
Golan, Shay ;
Aviv, Tzach ;
Groshar, David ;
Yakimov, Maxim ;
Zohar, Yaniv ;
Prokocimer, Yoad ;
Nadu, Andrei ;
Baniel, Jack ;
Domachevsky, Liran ;
Bernstine, Hanna .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (06) :773-778
1234